The aim of this review is to report on the value of11C-choline PET imaging as a diagnostic procedure for metastasis-directed therapies. Furthermore, the role of11C-choline PET/CT as a diagnostic tool for monitoring castration-resistant prostate cancer patients treated with systematic therapy is assessed. Finally, the role of11C-choline PET/CT in the prediction of survival in both castration-resistant prostate cancer patients and hormone-naïve patients is investigated.

Evaluation of prostate cancer with11C-Choline PET/CT for treatment planning, response assessment, and prognosis

Picchio, Maria;
2016-01-01

Abstract

The aim of this review is to report on the value of11C-choline PET imaging as a diagnostic procedure for metastasis-directed therapies. Furthermore, the role of11C-choline PET/CT as a diagnostic tool for monitoring castration-resistant prostate cancer patients treated with systematic therapy is assessed. Finally, the role of11C-choline PET/CT in the prediction of survival in both castration-resistant prostate cancer patients and hormone-naïve patients is investigated.
2016
11C-choline PET/CT; Metastasis-directed therapies; PET-guided therapies; Salvage lymph node dissection; Salvage radiotherapy; Choline; Evidence-Based Medicine; Humans; Image Enhancement; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment (Health Care); Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Radiology, Nuclear Medicine and Imaging
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/75567
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact